Singapore markets close in 38 minutes
Straits Times Index
3,297.70 +7.00 (+0.21%) Nikkei
38,179.46 -49.65 (-0.13%) Hang Seng
19,108.78 +145.10 (+0.77%) FTSE 100
8,442.45 +8.69 (+0.10%) Bitcoin USD
62,782.01 +1,952.98 (+3.21%) CMC Crypto 200
1,289.11 +28.90 (+2.30%)
Bio-Rad Laboratories, Inc. (BUWA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:20AM CEST. Market open.
| Previous close | 257.00 |
| Open | 260.70 |
| Bid | 260.70 x 5000 |
| Ask | 263.20 x 5000 |
| Day's range | 260.70 - 260.70 |
| 52-week range | 248.50 - 383.80 |
| Volume | |
| Avg. volume | 8 |
| Market cap | 7.559B |
| Beta (5Y monthly) | 0.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Here's What Analysts Are Forecasting For Bio-Rad Laboratories, Inc. (NYSE:BIO) After Its First-Quarter Results
The first-quarter results for Bio-Rad Laboratories, Inc. ( NYSE:BIO ) were released last week, making it a good time to...
- Zacks
Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Bio-Rad's (BIO) Clinical Diagnostics arm registers growth in Q1, primarily driven by an increased demand for quality control, blood typing, and diabetes products.
- Insider Monkey
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Laboratories, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon everyone, and welcome to today’s Bio-Rad First Quarter 2024 Earnings Results Conference Call. At this […]
© 2024 Yahoo. All rights reserved.